KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLiabilities and Shareholders EquityLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Receivables - Accured (2023 - 2025)

National Health Investors (NHI) has disclosed Revenue - Other for 17 consecutive years, with -$39.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue - Other rose 67.19% year-over-year to -$39.7 million, compared with a TTM value of -$191.7 million through Dec 2025, up 5.98%, and an annual FY2025 reading of -$191.7 million, up 5.98% over the prior year.
  • Receivables - Accured was $218.7 million for Q4 2025 at National Health Investors, up from $43.1 million in the prior quarter.
  • Across five years, Receivables - Accured topped out at $218.7 million in Q4 2025 and bottomed at $8.6 million in Q2 2023.
  • Average Receivables - Accured over 3 years is $69.9 million, with a median of $34.2 million recorded in 2024.
  • The sharpest move saw Revenue - Other tumbled 7383400.0% in 2021, then skyrocketed 1961600.0% in 2022.
  • Year by year, Revenue - Other stood at $25.6 million in 2021, then plummeted by 266.14% to -$42.5 million in 2022, then surged by 143.19% to $18.3 million in 2023, then plummeted by 758.85% to -$120.9 million in 2024, then skyrocketed by 67.19% to -$39.7 million in 2025.
  • Business Quant data shows Revenue - Other for NHI at -$39.7 million in Q4 2025, -$40.8 million in Q3 2025, and -$56.3 million in Q2 2025.